Lilly Oncology Taking 'Aggressive' Position

Posted: Updated:
(Image of Sue Mahony courtesy of Eli Lilly and Co.) (Image of Sue Mahony courtesy of Eli Lilly and Co.)
INDIANAPOLIS -

The president of Lilly Oncology says the company has a "strong base" of existing and potential treatments to fuel a new strategy for its cancer-fighting pipeline. During an earnings call with investors Tuesday morning, Sue Mahony said the company's oncology unit will be more aggressive, particularly when it comes to potential treatments in earlier stages "that clear a high bar." Officials say Lilly Oncology will sharpen its focus on 10 internal assets, seven of which are currently in the pipeline.

Additionally, Mahony says, Lilly Oncology could continue to connect with other drug makers on partnerships to help drive treatments to market like one signed with Merck & Co. Inc. (NYSE: MRK) earlier this year. The goal, she says, is to boost business development. "Specifically, we will actively pursue assets that combine rationally with our existing products, serve as new potential foundational agents and enable new immuno-oncology breakthroughs," Mahony said. "The good news is that there is a lot of external innovation in oncology, and we intend to be much more active in this space to ensure we have a competitive pipeline going forward."

During a retooling of its business units announced earlier this year, Mahony stayed on as a senior vice president and as president of Lilly Oncology.

Senior Vice President of Global Development and Medical Affairs Levi Garraway, who joined the company in January, says Lilly Oncology is positioned for a "remarkable" opportunity. He says "the vast majority of our internal R&D dollars" will now be focused on the aforementioned seven early-to-mid-stage assets in its oncology pipeline. One potential treatment, Abemaciclib, is awaiting regulatory approval, while several others are in the first, second or third phases of the development process. "We are giving ourselves flexibility to bet more aggressively on portfolio assets with the highest foundational potential," Garraway said, "while de-risking others externally, and importantly, making room to bring external innovation into our oncology portfolio."

During its second quarter earnings report Tuesday, Lilly detailed profit of more than $1 billion, a 35 percent increase from the same period a year earlier, and it revised previous full-year research and development investment expectations to a range of $5 billion to $5.2 billion.

Lilly Oncology President Sue Mahony says the company could continue to connect with other drug makers on partnerships to help drive treatments to market.
  • Perspectives

    • Making Numbers Work Harder For You

      Sencha CEO Art Landro believes the world has created more data in the last two years than in the preceding 5,000, and that we'll probably create even more than that before this year ends. In every aspect of our lives, we're absolutely drowning in data.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Indianapolis Among Amazon 'HQ2' Finalists

      Seattle-based Amazon.com Inc. (Nasdaq: AMZN) has named Indianapolis one of 20 finalists for the location of a second corporate headquarters. The company accepted bids late last year for what it expects to be a more than $5 billion investment that could bring up to 50,000 jobs with it. Chicago and Columbus, Ohio were the other two Midwest cities still in the running. Amazon says its "HQ2" will be "a full equal to our current campus in Seattle."

    • Anthem HQ Shifting to Different Downtown Location

      Indianapolis-based Anthem Inc. (NYSE: ANTM) says it is exiting from one of the city's most prominent office locations. Our partners at WIBC report the company is not renewing its lease at 120 Monument Circle, which has served as its primary corporate office since the early 1990s. The insurer's lease is set to run out at year's end and, without giving a timeline, a company spokesperson said...

    • Sony DADC to Lay Off Hundreds in Terre Haute

      Sony DADC has announced plans to lay off 375 workers at its Terre Haute facility. In a notice to the Indiana Department of Workforce Development, the company says the layoffs are due to its decision to outsource the music and video manufacturing operations at the facility. A spokeswoman for Sony DADC tells our partners at WTHI-TV the move will affect more than half the employees at the Vigo County location.

    • Hogsett: Amazon Announcement 'Speaks Volumes'

      Indianapolis Mayor Joe Hogsett says Seattle-based Amazon.com Inc. (Nasdaq: AMZN) choosing the city as one of 20 finalists for its second corporate headquarters shows Indy is "punching above our weight" as an attractive tech hub. He says Indianapolis is one of the least-populated metropolitan areas on the list. The project, announced late last year, is expected to bring a more than $5 billion investment and ultimately up to 50,000 jobs. In an interview with...

    • Committee Ices Carryout Cold Beer Bill

      The Senate Committee on Public Policy has voted down a bill that would've allowed carryout cold beer to be sold in additional locations like convenience stores, grocery stores and drug stores. The commission voted against Senate Bill 26 by a tally of 9-1 after three hours of testimony that mostly involved business owners and industry group representatives. Senator Tim Lanane () was the only yes vote, arguing for passage so the full Senate could make amendments.